CWA Asset Management Group’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CGTX
DC
EWM
BSB
BIA
VCM
CWA Asset Management Group's CGTX Position: Q2 2026 in Review
CWA Asset Management Group reduced its Cognition Therapeutics (CGTX) stake by 8.9% in Q2 2026, selling an estimated $2.66K and leaving 23,000 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #703.
CWA Asset Management Group first reported a position in CGTX in Q3 2025 and has held it in 4 quarters since. The position peaked at $34.1K in Q4 2025. 6 funds tracked by Wall St. Rank hold CGTX as of Q2 2026.
- CWA Asset Management Group held 23,000 shares of Cognition Therapeutics worth $26.4K as of Q2 2026.
- CWA Asset Management Group sold 2,250 Cognition Therapeutics shares in Q2 2026, an estimated $2.66K.
- Cognition Therapeutics made up ﹤0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #703 holding.
- CWA Asset Management Group first reported a position in Cognition Therapeutics in Q3 2025 and has held it in 4 quarters since.
- CWA Asset Management Group's Cognition Therapeutics position peaked at $34.1K in Q4 2025.
- 6 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q2 2026.
Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.